HomeHealthLab Study Claims A Common Drug Can Decrease COVID-19 Infection By Up...

Lab Study Claims A Common Drug Can Decrease COVID-19 Infection By Up To 70% Read In Detail

Coronavirus diseases could be diminished by as much as 70% by the utilization of a medication that has been supported by most nations present on the planet, including the U.S. Food and Drug Administration (FDA) and the UK’s National Institute for Health and Care Excellence (NICE), as per another examination.

The research is directed in the lab by a global joint effort of specialists who said that outcomes showed a 70% decreased possibility of contamination by SARS-CoV-2 could be conceivable by an authorized medication by and large utilized for the treatment of diseases like undeniable degrees of cholesterol and lipids which is present in the bloodstream of the human body.

A research team from two institutes, the University of Birmingham and Keele University in the U.K. and the San Raffaele Scientific Institute in Italy revealed that by using the fenofibrate(tablets that help to lower down the bad cholesterol as well as fats from the body) covid could be controlled.

Recent Article: An 18-year-old Pregnant Girl Attacked by a Group of Young Girls who Loses Her Unborn Child. Read Full News Here.

The researchers said that it could be the most effective tablet to be used to cure the SARS-COV-2 virus of the human’s cells.

According to the experts, they said that they are going to take a drug by using the proper amount of fenofibrate in it, in order to reduce the covid-virus.

But we couldn’t believe anything… So a research team also stood up and said that the medicine does need a proper clinical trial on the COVID-19 convalescence.

At present, there are two clinical preliminaries being completed with such patients in research being driven by the Hospital of the University of Pennsylvania in the US and Hebrew University of Jerusalem in Israel.

Recent Article: South Carolina New Traffic Law Takes Effect Sunday! Read Law in Details

“The development of new more infectious SARS-CoV-2 variants has resulted in a rapid expansion in infection rates and deaths in several countries around the world, especially the UK, US, and Europe. Whilst vaccine programs will hopefully reduce infection rates and virus spread in the longer term, there is still an urgent need to expand our arsenal of drugs to treat SARS-CoV-2-positive patients.”- said comparing creator Dr Farhat Khanim, of the University of Birmingham in the U.K.

You can comment your thought on this article. And stay tuned with The East County Gazette to get more and the latest news updates from our experienced writers.

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Latest Article